Notably, differential cell–cell junction expression at these barrier sites [78] may provide a unique route for NMO IgG to enter the cerebrospinal fluid (CSF) and access AQP4-expressing targets in the brain parenchyma. The gene discussed is AQP4; the disease is neuromyelitis optica.